Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
643-671
Author(s):
Robert R. Luedtke and Robert H. Mach
Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
1-26
Author(s):
Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco and Luigi Agnati
Gene Therapy for Ischemic Brain Diseases
Journal:
Current Gene Therapy
Volume:
3
Page:
49-58
Author(s):
Youichi Saitoh, Amami Kato, Yasushi Hagihara, Yasufumi Kaneda and Toshiki Yoshimine
Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types
Journal:
Current Gene Therapy
Volume:
2
Page:
415-426
Author(s):
David S. Latchman
Neuroprotective Gene Therapy for Parkinson’s Disease
Journal:
Current Gene Therapy
Volume:
2
Page:
451-483
Author(s):
L. Tenenbaum, A. Chtarto, E. Lehtonen, D. Blum, V. Baekelandt, T. Velu, J. Brotchi and M. Levivier
On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Journal:
Current Drug Metabolism
Volume:
3
Page:
379-424
Author(s):
Amit S. Kalgutkar, Deepak K. Dalvie, John P. O'Donnell, Timothy J. Taylor and Diana C. Sahakian
The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
399-411
Author(s):
M. J. O'Neill, T. K. Murray, V. Lakics, N. P. Visanji and S. Duty
Positron Emission Tomography and Brain Monoamine Neurotransmission - Entries for Study of Drug Interactions
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1417-1434
Author(s):
P. Hartvig, M. Bergstrom, G. Antoni and B. Langstrom
Annexins as Neuroprotective Agents in the Central Nervous System
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
87-107
Author(s):
Joanna Bandorowicz-Pikula
Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
141-147
Author(s):
C. A. Tamminga and A. Carlsson